Showing results (11-20 of 520) with videos related to

Sort By:
Pageof 52
Annals of Surgery|August 25, 2025
Recurrence-free Survival as a Surrogate Endpoint for Overall Survival in Resectable Esophageal Cancer: Integrated Analysis of Individual Patient Data From Phase III TrialsJun Okui, Satoru Matsuda, Kengo Nagashima, et al.
The British Journal of Surgery|June 26, 2025
Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trialsJun Okui, Kengo Nagashima, Satoru Matsuda, et al.
Annals of Surgery|July 15, 2022
Real-world Evaluation of the Efficacy of Neoadjuvant DCF Over CF in Esophageal Squamous Cell Carcinoma: Propensity Score-matched Analysis From 85 Authorized Institutes for Esophageal Cancer in JapanSatoru Matsuda, Yuko Kitagawa, Ryo Takemura, et al.
Esophagus : Official Journal of the Japan Esophageal Society|November 2, 2022
A nationwide validation of the prognostic impact of pathological response and the distribution of recurrence patterns in responders after neoadjuvant chemotherapy for esophageal squamous cell carcinomaSatoru Matsuda, Yuko Kitagawa, Hirofumi Kawakubo, et al.
The British Journal of Surgery|February 17, 2026
Survival After Pathological Complete Response Following Neoadjuvant Chemotherapy vs Chemoradiotherapy in Esophageal Squamous Cell CarcinomaJun Okui, Satoru Matsuda, Kengo Nagashima, et al.
Journal of the National Cancer Institute|January 7, 2026
Conditional recurrence-free survival after curative esophagectomy: individual patient data analysis of 11 trialsJun Okui, Satoru Matsuda, Kengo Nagashima, et al.
World Journal of Gastrointestinal Surgery|February 7, 2022
Association of anastomotic leakage with long-term oncologic outcomes of patients with esophagogastric junction cancerMasashi Takeuchi, Hirofumi Kawakubo, Satoru Matsuda, et al.
Annals of Surgical Oncology|December 17, 2022
Development and Validation of a Predictive Model of Therapeutic Effect in Patients with Esophageal Squamous Cell Carcinoma Who Received Neoadjuvant Treatment: A Nationwide Retrospective Study in JapanAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgical Oncology|June 1, 2023
Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from A Japanese Nationwide StudyAkihiko Okamura, Masayuki Watanabe, Jun Okui, et al.
Annals of Surgery|December 20, 2022
Nationwide Validation Study of the Prognostic Significance of Stratification Using Pathological Stage and Response to Neoadjuvant Chemotherapy for Esophageal Squamous Cell CarcinomaSatoru Matsuda, Yuko Kitagawa, Jun Okui, et al.
Pageof 52